We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ProAssurance Continues to Impress: Time to Buy the Stock?
Read MoreHide Full Article
On Sep 12, 2016, we issued an updated research report on ProAssurance Corporation (PRA - Free Report) .
The Birmingham-based company caters to the property and casualty insurance needs of physicians, dentists, other healthcare providers and healthcare facilities through its subsidiaries. A major portion of the company’s economic and geographic growth is driven by mergers and acquisitions, which are supported by its financial strength. Moreover, the company is on track to bolster its operating efficiency. In keeping with this, it has started to simplify its business structure by merging its subsidiaries.
Despite persistently low interest rates and continuous threats from new entrants, ProAssurance’s core operations have been improving significantly over the past few quarters. Both gross premiums written and net premiums earned reflected steady growth in the initial quarters of 2016.
The company’s secure capital position has not only helped it grow inorganically, but has also supported it to create value for investors by returning more via share buybacks as well as paying quarterly dividends and special dividends. ProAssurance bought back about 0.02 million shares worth approximately $0.8 million in the last reported quarter and still has $109.6 million remaining under its authorization. This month, the board of directors of the company announced a cash dividend of $0.31 per common share, which is payable on Oct 7.
This Zacks Rank #2 (Buy) insurer also carries an investment grade rating by virtue of its strong risk-adjusted capitalization, favorable operating performance and strong business profile. Recently, A.M. Best reiterated the issuer credit ratings (ICR) of “a-” of the company and affirmed both the financial strength rating (FSR) and the ICR of its indirect subsidiaries.
However, volatility in premium retention in the company’s physician business, weak investment portfolio containing fixed income securities, poor expense management remain headwinds.
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
ProAssurance Continues to Impress: Time to Buy the Stock?
On Sep 12, 2016, we issued an updated research report on ProAssurance Corporation (PRA - Free Report) .
The Birmingham-based company caters to the property and casualty insurance needs of physicians, dentists, other healthcare providers and healthcare facilities through its subsidiaries. A major portion of the company’s economic and geographic growth is driven by mergers and acquisitions, which are supported by its financial strength. Moreover, the company is on track to bolster its operating efficiency. In keeping with this, it has started to simplify its business structure by merging its subsidiaries.
Despite persistently low interest rates and continuous threats from new entrants, ProAssurance’s core operations have been improving significantly over the past few quarters. Both gross premiums written and net premiums earned reflected steady growth in the initial quarters of 2016.
The company’s secure capital position has not only helped it grow inorganically, but has also supported it to create value for investors by returning more via share buybacks as well as paying quarterly dividends and special dividends. ProAssurance bought back about 0.02 million shares worth approximately $0.8 million in the last reported quarter and still has $109.6 million remaining under its authorization. This month, the board of directors of the company announced a cash dividend of $0.31 per common share, which is payable on Oct 7.
This Zacks Rank #2 (Buy) insurer also carries an investment grade rating by virtue of its strong risk-adjusted capitalization, favorable operating performance and strong business profile. Recently, A.M. Best reiterated the issuer credit ratings (ICR) of “a-” of the company and affirmed both the financial strength rating (FSR) and the ICR of its indirect subsidiaries.
However, volatility in premium retention in the company’s physician business, weak investment portfolio containing fixed income securities, poor expense management remain headwinds.
Stocks to Consider
Some better-ranked stocks from the same space include Allied World Assurance Company Holdings, AG (AWH - Free Report) , National Interstate Corporation (NATL - Free Report) and NMI Holdings Inc (NMIH - Free Report) . All of the stocks sport Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>